Who owns TEVA
632 institutions reported holding TEVA for 2026Q1, together 57% of the company, more than the 614 a quarter earlier.
632
Institutions reporting a position · as of 2026Q1 · up from 614 the quarter before
- Shares held by institutions
- 673.4M
Shares held by institutions · 57% of the company · long US equity positions only, as reported on Form 13F
- Reported value
- $20.1B
Reported value · at 2026-03-31 prices, not today's
- Top 5 holders
- 20%
Top 5 holders · of the whole company, between five filers
Details›
- Reporting quarter2026-03-31
- 2026Q1
- Quarters on record
- 52
- New positions
- 89
- Positions exited
- 73
- Added to
- 215
- Reduced
- 180
- Top 10 holdersof the company
- 33%
| Quarter | Filers | Shares | Reported value |
|---|---|---|---|
| 2026Q1 | 632 | 673.4M | $20.1B |
| 2025Q4 | 614 | 686.8M | $21.4B |
| 2025Q3 | 540 | 657.0M | $13.3B |
| 2025Q2 | 526 | 719.3M | $11.9B |
| 2025Q1 | 547 | 713.7M | $11.0B |
| 2024Q4 | 571 | 665.8M | $14.7B |
| 2024Q3 | 539 | 635.8M | $11.3B |
| 2024Q2 | 530 | 607.9M | $9.88B |
| 2024Q1 | 475 | 570.7M | $8.05B |
| 2023Q4 | 439 | 577.1M | $6.07B |
| 2023Q3 | 428 | 554.4M | $5.66B |
| 2023Q2 | 423 | 495.1M | $3.73B |
| 2023Q1 | 435 | 560.2M | $4.95B |
| 2022Q4 | 419 | 561.4M | $5.12B |
| 2022Q3 | 428 | 560.0M | $4.55B |
| 2022Q2 | 451 | 506.6M | $3.85B |
| Holder | Shares | % of company | Value |
|---|---|---|---|
| BlackRock Inc. | 65.1M | 5.5% | $1.96B |
| Harel Insurance Investments & Financial Services Ltd. | 46.0M | 3.9% | $1.38B |
| Phoenix Holdings Ltd. | 42.8M | 3.6% | $1.29B |
| WCM INVESTMENT MANAGEMENT, LLC | 40.8M | 3.5% | $1.16B |
| MENORA MIVTACHIM HOLDINGS LTD. | 39.6M | 3.4% | $1.19B |
| Clal Insurance Enterprises Holdings Ltd | 38.4M | 3.3% | $1.15B |
| Migdal Insurance & Financial Holdings Ltd. | 37.9M | 3.2% | $1.14B |
| FMR LLC | 33.1M | 2.8% | $998M |
| Exor N.V. | 27.8M | 2.4% | $836M |
| STATE STREET CORP | 17.8M | 1.5% | $536M |
SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.
reading the register…
Drug Manufacturers - Specialty & Generic
Ranks #15 of 28 by Smart Score